Nukkleus Inc. Logo

Nukkleus Inc.

NUKK

(0.5)
Stock Price

2,18 USD

-1193.43% ROA

155.19% ROE

-0.32x PER

Market Cap.

4.962.036,00 USD

-15.92% DER

0% Yield

-230.74% NPM

Nukkleus Inc. Stock Analysis

Nukkleus Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Nukkleus Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 ROE

The stock's ROE indicates a negative return (-92.13%) on shareholders' equity, suggesting poor financial performance.

3 ROA

The stock's ROA (-96.89%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

4 PBV

The stock's elevated P/BV ratio (3.91x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (-1), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Nukkleus Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Nukkleus Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Nukkleus Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Nukkleus Inc. Revenue
Year Revenue Growth
2013 12.000
2014 102.951 88.34%
2015 32.469 -217.07%
2016 9.700.000 99.67%
2017 24.000.000 59.58%
2018 19.200.000 -25%
2019 19.200.000 0%
2020 19.200.000 0%
2021 19.286.964 0.45%
2022 21.513.474 10.35%
2023 20.848.224 -3.19%
2023 16.222.388 -28.52%
2024 700.856 -2214.65%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Nukkleus Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2013 0
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Nukkleus Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2013 113.106
2014 123.850 8.68%
2015 62.980 -96.65%
2016 373.665 83.15%
2017 289.693 -28.99%
2018 476.801 39.24%
2019 1.015.793 53.06%
2020 413.115 -145.89%
2021 557.071 25.84%
2022 5.485.773 89.85%
2023 3.947.288 -38.98%
2023 2.840.773 -38.95%
2024 6.059.072 53.12%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Nukkleus Inc. EBITDA
Year EBITDA Growth
2013 -20.000
2014 -50.260 60.21%
2015 -45.176 -11.25%
2016 -252.415 82.1%
2017 -112.693 -123.98%
2018 -176.801 36.26%
2019 -715.793 75.3%
2020 -113.115 -532.8%
2021 -463.390 75.59%
2022 -4.844.295 90.43%
2023 -2.479.636 -95.36%
2023 -1.493.655 -66.01%
2024 -5.491.208 72.8%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Nukkleus Inc. Gross Profit
Year Gross Profit Growth
2013 5.724
2014 73.590 92.22%
2015 17.804 -313.33%
2016 121.250 85.32%
2017 300.000 59.58%
2018 300.000 0%
2019 300.000 0%
2020 300.000 0%
2021 93.953 -219.31%
2022 -661.396 114.21%
2023 -632.072 -4.64%
2023 -64.929 -873.48%
2024 501.904 112.94%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Nukkleus Inc. Net Profit
Year Net Profit Growth
2013 -137.382
2014 -50.260 -173.34%
2015 -45.176 -11.25%
2016 -260.267 82.64%
2017 -136.851 -90.18%
2018 -212.187 35.5%
2019 -696.153 69.52%
2020 -106.602 -553.04%
2021 -940.744 88.67%
2022 -16.156.402 94.18%
2023 -4.838.976 -233.88%
2023 -3.272.089 -47.89%
2024 -6.464.964 49.39%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Nukkleus Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2013 0
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 -2 100%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Nukkleus Inc. Free Cashflow
Year Free Cashflow Growth
2013 -87.840
2014 -30.806 -185.14%
2015 -59.487 48.21%
2016 0 0%
2017 48.642 100%
2018 -51.005 195.37%
2019 -138.431 63.15%
2020 59.335 333.3%
2021 295.887 79.95%
2022 1.615.606 81.69%
2023 1.255.324 -28.7%
2024 -740.509 269.52%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Nukkleus Inc. Operating Cashflow
Year Operating Cashflow Growth
2013 -87.840
2014 -30.806 -185.14%
2015 -59.487 48.21%
2016 0 0%
2017 48.642 100%
2018 -1.005 4940%
2019 -138.431 99.27%
2020 59.335 333.3%
2021 295.887 79.95%
2022 1.615.606 81.69%
2023 1.255.785 -28.65%
2024 -740.509 269.58%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Nukkleus Inc. Capital Expenditure
Year Capital Expenditure Growth
2013 0
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 50.000 100%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 461 100%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Nukkleus Inc. Equity
Year Equity Growth
2013 19.153
2014 -1.657 1255.88%
2015 -22.132 92.51%
2016 -236.376 90.64%
2017 -351.345 32.72%
2018 -563.532 37.65%
2019 -1.293.645 56.44%
2020 -1.394.207 7.21%
2021 12.021.323 111.6%
2022 10.890.580 -10.38%
2023 7.985.912 -36.37%
2024 -12.230.130 165.3%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Nukkleus Inc. Assets
Year Assets Growth
2013 22.660
2014 12.904 -75.6%
2015 0 0%
2016 1.176.809 100%
2017 1.104.951 -6.5%
2018 305.770 -261.37%
2019 203.001 -50.62%
2020 3.799.631 94.66%
2021 16.659.836 77.19%
2022 18.364.904 9.28%
2023 15.346.878 -19.67%
2024 1.120.125 -1270.1%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Nukkleus Inc. Liabilities
Year Liabilities Growth
2013 3.507
2014 14.561 75.92%
2015 22.132 34.21%
2016 1.413.185 98.43%
2017 1.456.296 2.96%
2018 869.302 -67.52%
2019 1.496.646 41.92%
2020 5.193.838 71.18%
2021 4.638.513 -11.97%
2022 7.474.324 37.94%
2023 7.360.966 -1.54%
2024 13.350.255 44.86%

Nukkleus Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.4
Net Income per Share
-0.91
Price to Earning Ratio
-0.32x
Price To Sales Ratio
0.87x
POCF Ratio
-1.55
PFCF Ratio
-1.81
Price to Book Ratio
-0.35
EV to Sales
1.22
EV Over EBITDA
-1.03
EV to Operating CashFlow
-2.52
EV to FreeCashFlow
-2.52
Earnings Yield
-3.09
FreeCashFlow Yield
-0.55
Market Cap
0,00 Bil.
Enterprise Value
0,01 Bil.
Graham Number
4.19
Graham NetNet
-0.91

Income Statement Metrics

Net Income per Share
-0.91
Income Quality
0.21
ROE
1.55
Return On Assets
-11.69
Return On Capital Employed
1.17
Net Income per EBT
1
EBT Per Ebit
1.02
Ebit per Revenue
-2.27
Effective Tax Rate
-0.01

Margins

Sales, General, & Administrative to Revenue
1.29
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.53
Gross Profit Margin
0.14
Operating Profit Margin
-2.27
Pretax Profit Margin
-2.31
Net Profit Margin
-2.31

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.19
Free CashFlow per Share
-0.19
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
1.26
Return on Tangible Assets
-11.93
Days Sales Outstanding
1.19
Days Payables Outstanding
25.61
Days of Inventory on Hand
39.7
Receivables Turnover
306.83
Payables Turnover
14.25
Inventory Turnover
9.19
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,85
Tangible Book Value per Share
-0.85
Shareholders Equity per Share
-0.85
Interest Debt per Share
0.14
Debt to Equity
-0.16
Debt to Assets
1.74
Net Debt to EBITDA
-0.29
Current Ratio
0.06
Tangible Asset Value
-0,01 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
-11398214
Working Capital
-0,01 Bil.
Intangibles to Total Assets
0.02
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
439132.5
Debt to Market Cap
0.39

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Nukkleus Inc. Dividends
Year Dividends Growth

Nukkleus Inc. Profile

About Nukkleus Inc.

Nukkleus Inc., a financial technology company, focuses on providing software and technology solutions for retail foreign exchange trading industry worldwide. The company primarily offers software, technology, customer sales and marketing, and risk management technology hardware and software solutions. It also offers financial services to enable conversion of fiat currencies to cryptocurrencies and vice versa. The company was formerly known as Compliance & Risk Management Solutions Inc. and changed its name to Nukkleus Inc. The company was incorporated in 2013 and is headquartered in Jersey City, New Jersey. Nukkleus Inc. operates as a subsidiary of Global Elite Holdings Ltd.

CEO
Mr. Menachem Shalom
Employee
12
Address
525 Washington Boulevard
Jersey City, 07310

Nukkleus Inc. Executives & BODs

Nukkleus Inc. Executives & BODs
# Name Age
1 Mr. Menachem Shalom
Chief Executive Officer & Director
70
2 Mr. Andrew Albert Kucharchuk M.B.A.
Chief Financial Officer
70

Nukkleus Inc. Competitors

Duo World, Inc. Logo
Duo World, Inc.

DUUO

(2.0)
Esker SA Logo
Esker SA

ESKEF

(0.8)
Nogin, Inc. Logo
Nogin, Inc.

NOGNW

(1.8)
Tautachrome, Inc. Logo
Tautachrome, Inc.

TTCM

(1.8)
Fernhill Corp. Logo
Fernhill Corp.

FERN

(2.2)
AiAdvertising, Inc. Logo
AiAdvertising, Inc.

AIAD

(2.2)
BASE, Inc. Logo
BASE, Inc.

BAINF

(1.2)
Ackroo Inc. Logo
Ackroo Inc.

AKRFF

(0.5)
Auddia Inc. Logo
Auddia Inc.

AUUDW

(1.0)